Skip to main content
Signal8

HALBERT DAVID D

SEC insider (Form 3/4/5 filer). CIK 0001034380. Director & 10% Owner at Caris Life Sciences, Inc. (CAI). 6 reported Form 4/5 transactions since Sep 2024; latest on May 15, 2026. Located in IRVING, TX.

Companies HALBERT DAVID D has filed insider reports for

  • Caris Life Sciences, Inc. (CAI): Director, Officer, 10% Owner, See Remarks
HALBERT DAVID D profile photo

HALBERT DAVID D

CIK: 0001034380

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Caris Life Sciences, Inc. logo
CAI

Caris Life Sciences, Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    May 15, 2026
    Tax Payment
    Direct
    40.7K shares at avg. $15.25$621K
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Mar 6, 2026
    Award
    Direct
    320.1K shares-
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Aug 11, 2025
    Tax Payment
    Direct
    142K shares at avg. $29.75$4.2M
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Jun 20, 2025
    Conversion
    Indirect
    104.8M shares-
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Jun 18, 2025
    Award
    Direct
    413.8K shares-
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Mar 25, 2025
    Award
    Direct
    360.8K shares-

1-6 of 6